ClinicalTrials.gg
CompletedNCT06828276i-CBTUpdated Nov 4, 2026

Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants

An interventional study of Culturally adapted i-CBT in Depressive Symptoms, Anxiety Symptoms and Grief, sponsored by Karolinska Institutet. Completed at 1 site in Sweden. Open to participants aged 15 Years to 29 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

How we know

Updated Nov 4, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Randomized
Ages
15 Years to 29 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 42 studies in Depression by Karolinska Institutet — 8 open to participants now, 11 under way, none of them phase 3. Depression · Karolinska Institutet.

Enrollment
22nd of 34
93 · median 130
Started
2025
with 4 others
No phase
31 of 42
5 open now
Registered
39th of 42
by date

Among the 42 studies in Depression by Karolinska Institutet, this one is the 22nd largest by enrollment of the 34 interventional ones that give a count, is one of 5 that started in 2025, is one of 31 with no phase, and was the 39th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

8 of the 42 studies in Depression by Karolinska Institutet are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 15 Years to 29 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Depression by Karolinska Institutet, or all of them as a file.
02

Study summary

The aim of this randomized controlled trial (RCT) is to investigate the effectiveness of a culturally adapted internet-based cognitive behavioral therapy (i-CBT) intervention in reducing symptoms of common mental health issues among Farsi/Dari-speaking youth migrants and refugees. Investigator hypothesizes that there will be a significant decrease in psychological symptoms after participants receive the intervention compared to a control group.

Read the detailed description

Participants who are included in the study will be allocated to the experimental group and the control group (waiting list). Participants will be invited to participate tailored i-CBT intervention over 10-weeks. Intervention covers common psychological issues. Participants will have access to support through a chatting function, during the interventional period. Intervention effects will be measured prior-treatment, post-treatment, and 6 months post-treatment.

03

Conditions studied

  • Depressive Symptoms
  • Anxiety Symptoms
  • Grief
  • Psychological Trauma
  • Insomnia
  • Resilience
  • Stress
  • Psychological Well Being
  • Marital Relationship
  • Wellbeing
  • Common Mental Health Problems
  • Rumination

Keywords

  • Refugee
  • Cognitive behavioral therapy
  • Psychological problems
  • Persian speaking
  • Psychological well-being
  • Youth
  • Mental problems
  • Resilience
  • Asylum seeker
04

Who can participate

Ages eligible
15 Years to 29 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between the ages of 15 and 29.
  • A score above the cut-off 1.75 on HSCL-25
  • Has a refugee or migrant background
  • Has a good and stable internet connection
  • Has access to a computer, tablet or smartphone
  • Is fluent in reading and writing Arabic
  • Has the ability to dedicate time to take part in the intervention for 6-10 weeks.

Exclusion criteria

Exclusion Criteria:

  • Is suffering from a severe mental illness, such as psychosis or severe depression.
  • Is suffering from substance abuse
  • Is undergoing a psychological treatment
  • Has a high risk of suicide
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
93 participants (actual)

Study arms

  • Experimental
    Active group

    Tailored I-CBT for mild to moderate common mental health problems over a 10-weeks-period.

    Behavioral: Culturally adapted i-CBT

  • No intervention
    Waiting-list

    Control group

Interventions

  • BehavioralCulturally adapted i-CBT

    A culturally and language adapted i-CBT intervention for Farsi/Dari speaking youth migrants and refugees. The intervention targets mild to moderate common mental health problems.

06

What researchers measure

Primary outcomes

  1. Hopkins Symptom Checklist-25 (HSCL-25)

    Assessment of anxiety and depressive symptoms. HSCL-25 consists of 25 items.Each item is rated on a scale from 1 to 4, where 1 means "Not at all" and 4 means "Extremely".Higher scores indicate a worse outcome, as they reflect greater severity of symptoms.

    Time frame: Pre-intervention, up to 5 weeks, immediately after the intervention, 6 months after completion of the intervention

Secondary outcomes

  1. Psychological Outcome Profiles (PSYCHLOPS)

    Impact of problematic area on function. PSYCHLOPS questionnaire consists of 4 items. These items are designed to capture the patient's main problem, the impact of this problem on their daily life, and their overall well-being. Each question in PSYCHLOPS is scored on a scale from 0 to 5, where 0 indicates no problem and 5 indicates the most severe problem. Higher scores indicate a worse outcome, as they reflect greater severity of problems or distress.

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

  2. Insomnia Severity Index (ISI)

    Assessment of severity of insomnia symptoms. ISI consists of 7 items, each rated on a scale from 0 to 4.Higher scores indicate a worse outcome, as they reflect more severe insomnia symptoms.

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

  3. Prolonged Grief Disorder (PG-13)

    Assessment of prolonged grief disorder. The PG-13 consists of 13 items, each rated on a scale from 1 to 5, where 1 means "Not at all" and 5 means "Several times a day". Higher scores indicate a worse outcome, as they reflect more severe symptoms of prolonged grief.

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

  4. Posttraumatic Stress Disorder Checklist (PCL-5)

    Assessment of symptoms of post-traumatic stress disorder. The PCL-5 consists of 20 items, each rated on a scale from 0 to 4. The total score ranges from 0 to 80. Higher scores indicate a worse outcome, as they reflect greater severity of PTSD symptoms.

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

  5. The World Health Organization-Five Well-Being Index (WHO-5)

    Assessment of subjective psychological well-being.The WHO-5 consists of 5 items, each rated on a scale from 0 to 5. Higher scores indicate a better outcome, as they reflect higher levels of well-being.

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

  6. Brief Resilience Scale (BRS)

    Assessment of resilience.The BRS consists of 6 items, each rated on a scale from 1 to 5. Higher scores indicate a better outcome, as they reflect greater resilience.

    Time frame: Pre-intervention, immediately after the intervention, 6 months after completion of the intervention

  7. Client Satisfaction Questionnaire (CSQ-3)

    Assessment of the levels of satisfaction of the participant with the intervention.CSQ-3 consists of 3 items. Each item is rated on a scale from 1 to 4. Higher scores indicate a better outcome, as they reflect greater satisfaction with the services received.

    Time frame: Immediately after the intervention, 6 months after completion of the intervention

07

Study locations

1 site
  • Karolinska Institutet
    Stockholm, 113 64, Sweden
08

References and documents

Publications

  • Demetry Y, Wasteson E, Lindegaard T, Abuleil A, Geranmayeh A, Andersson G, Shahnavaz S. Individually Tailored and Culturally Adapted Internet-Based Cognitive Behavioral Therapy for Arabic-Speaking Youths With Mental Health Problems in Sweden: Qualitative Feasibility Study. JMIR Form Res. 2023 Nov 24;7:e46253. doi: 10.2196/46253. PubMed 37999955 ↗
  • Lindegaard T, Wasteson E, Demetry Y, Andersson G, Richards D, Shahnavaz S. Investigating the potential of a novel internet-based cognitive behavioural intervention for Dari and Farsi speaking refugee youth: A feasibility study. Internet Interv. 2022 Apr 1;28:100533. doi: 10.1016/j.invent.2022.100533. eCollection 2022 Apr. PubMed 35433279 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2025 to primary completion in Mar 2026, 12 months.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 12 months is below that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: primary completion Dec 2026 → Mar 2026 and completion Dec 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 22, 2025
First posted
Feb 14, 2025
StartActual
Mar 25, 2025
Primary completionActual
Mar 30, 2026was Dec 2026
CompletionActual
Sep 30, 2026was Dec 2026
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 4, 2026
Primary completion
Dec 31, 2026→Mar 30, 2026 (actual)
Nov 4, 2026
Study completion
Dec 31, 2026→Sep 30, 2026 (actual)
Nov 4, 2026
Enrollment
128 (estimated)→93 (actual)
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Recruiting→Completed
    Primary completion Dec 31, 2026→Mar 30, 2026 (now actual)
    Study completion Dec 31, 2026→Sep 30, 2026 (now actual)
    Enrollment 128 (estimated)→93 (actual)
    + 2 other changes: contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06828276
Responsible party
Shervin Shahnavaz (PhD, Lecturer, Karolinska Institutet) — Principal investigator
First posted
Feb 14, 2025
Start date
Mar 25, 2025
Primary completion
Mar 30, 2026
Completion
Sep 30, 2026
Last update
Nov 4, 2026

Study contacts

Gerhard Andersson, PhD
principal investigator · Linkoeping University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion